OUTLOOK THERAPEUTICS INC (OTLK)
US69012T3059 - Common Stock
| MRQ (2024-6-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 17.40M | 14.48M | 12.54M | |||
| Cash Equivalents | 32.02M | 23.39M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 13.59M | 7.59M | 10.12M | 7.03M | 5.41M | |||
| Total Current Assets | 45.62M | 30.98M | 27.52M | 21.51M | 17.94M | |||
| Non-Current Assets | ||||||||
| PPE Net | 286.46K | 26.00K | 70.00K | 275.00K | 494.00K | |||
| Investments And Advances | 708.39K | 794.00K | 805.00K | 854.00K | 900.00K | |||
| Other Non-Current Assets | 479.23K | 501.00K | 132.00K | 175.00K | 394.00K | |||
| Total Non-Current Assets | 1.47M | 1.32M | 1.01M | 1.30M | 1.79M | |||
| TOTAL ASSETS | 47.09M | 32.30M | 28.53M | 22.81M | 19.73M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 32.43M | 35.55M | 10.93M | 931.00K | 3.69M | |||
| Accrued Expenses | 2.71M | 2.75M | 3.46M | 1.77M | 7.95M | |||
| Accounts Payable | 5.55M | 6.58M | 3.49M | 2.20M | 2.40M | |||
| Other Current Liabilities | 1.86M | 1.86M | 1.86M | 1.86M | 1.86M | |||
| Total Current Liabilities | 42.55M | 46.73M | 19.73M | 6.75M | 15.89M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 4.00K | 10.90M | 947.00K | |||
| Other Non-Current Liabilities | 88.21M | 6.00K | 57.00K | 550.00K | 71.00K | |||
| Total Non-Current Liabilities | 88.21M | 6.00K | 61.00K | 11.45M | 1.02M | |||
| TOTAL LIABILITIES | 130.77M | 46.74M | 19.79M | 18.20M | 16.91M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -548.98M | -467.92M | -408.94M | -342.88M | -289.72M | |||
| Additional Paid In Capital | 465.07M | 450.88M | 415.40M | 345.73M | 291.27M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 234.06K | 2.60M | 2.27M | 1.76M | 1.27M | |||
| Shares Outstanding | 23.41M | 13.01M | 11.37M | 8.82M | 6.36M | |||
| Tangible Book Value per Share | -3.57 | -1.11 | 0.77 | 0.52 | 0.44 | |||
| Total Shareholders' Equity | -83.67M | -14.44M | 8.74M | 4.61M | 2.83M | |||
| TOTAL LIABILITIES AND EQUITY | 47.09M | 32.30M | 28.53M | 22.81M | 19.73M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.00 | 2.37 | 0.34 | |||
| Current Ratio | 1.07 | 0.66 | 1.39 | 3.19 | 1.13 | |||
| Return On Assets (ROA) | -199.71% | -182.60% | -231.53% | -233.06% | -247.68% | |||
| Return On Equity (ROE) | N/A | N/A | -756.01% | -1153.97% | -1729.43% | |||
All data in USD , ROIC based on taxRate of 0.21